Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV aminophylline and hydrocortisone pilot study in severe asthma
2014-000182-45Phase 4Terminated
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aminophylline and hydrocortisone sodium succinate in severe asthma, sponsored by Royal Brompton and Harefield hospitals. Primary endpoint: Lung function pre and post IV aminophylline/IV hydrocortisone treatment. Started Apr 2014; status: terminated.
02
Drugs
aminophyllinehydrocortisone sodium succinate
03
Conditions
severe asthma
Beyond the preview
Go deeper on 2014-000182-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000182-45.